http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20030046777-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5b9f9cd8f41ddd9b8e5bc26a4d68518
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_694f81756e92c09f407b691917f41467
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P13-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
filingDate 2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1458c00b9e35b782e4a32a821d119c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8194dabe37b5acab21a3355e43e362e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f8dbabf024c12654519e37160fb86ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07753ec1deecc2790025225e0344fedc
publicationDate 2003-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20030046777-A
titleOfInvention Method for preparing chiral amines
abstract The present invention relates to a method for preparing a chiral amine, which method is prepared by reacting a ketoxime, palladium, lipase, acyl group donor compound and tertiary amine represented by the following formula (I) to prepare an amide of the formula (IV) Hydrolysis of the amide.n n n [Formula I]n n n n n n n n [Formula IV]n n n n n n n n (In the above formulas I and IV,n n n R 1 is hydrogen, an alkyl group, an alkoxy group, a phenyl group, a phenyl group substituted with an alkyl group,n n n R 2 and R 3 are hydrogen or an alkyl group, or R 2 and R 3 is a ring to which the alkyl group is a C 1 to C 3 alkyl group substituted with hydrogen, oxygen, nitrogen, sulfur or halogen, wherein R The linking ring of 2 -R 3 is represented by-(CH 2 ) n -X-, n is a natural number of 1 to 3, X is a methylene group, oxygen, sulfur or nitrogen atom,n n n Y is -CH = CH-, -CH = N-, sulfur or oxygen,n n n R 4 is an alkyl group of C 1 to C 5 substituted with oxygen or halogen.)n n n In the preparation method of the present invention, the chiral amine can be stereoselectively formed in the amide form from the achiral matrix ketoxime by mixing a metal catalyst palladium and a biocatalyst lipase, and the synthesis method of the chiral amine according to the present invention is known in the art. On the contrary, it is a new technology that uses a metal catalyst and a biocatalyst, and has the advantage of using ketoxime, which is relatively easy to manufacture, as a substrate, and providing a high yield of chiral amine with high optical purity.n n n Synthesis method of the present invention is a synthetic method with a large versatility applicable to the synthesis of secondary amines of various structures, it can replace the conventional pure chemical synthesis method or biochemical synthesis method. Chiral amines that can be prepared through the present invention can be usefully used as intermediate raw materials for various chiral pharmaceuticals and fine chemicals.
priorityDate 2001-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452927767
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5HKP6
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10563
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41773
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID184068
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID187316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14818447
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ3UT41
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID184306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412215776
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3921488
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID84753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414886711
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID187940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448334331
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21881112
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26504
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID292
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID188437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID735802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6350
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8284735
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23938
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ93MW7
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID292
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414491800
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414870537
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID84753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425901710
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A3Q1M1X5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R3
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID291437
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID185178
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C0R4
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453063016
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9VG48
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451245303
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID886728
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ55EU1
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3919527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID34152
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID190108
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCD4A9L7
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID185800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO59952
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID185840
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5U780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415831845
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13221340
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16891
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167902
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559573
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419515599
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA8WGN9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4811470
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP61872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393625
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447745103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970

Total number of triples: 105.